BCHE and Alzheimer disease: Two additional studies (88, 89) that assessed the impact of cholinesterase inhibitors on gait performance revealed that donepezil and galantamine improved AD patients’ ability to adapt their gait patterns to tasks requiring attention and increased gait speed.